Analysis of chromatin preparations from [3H]glucosamine-labelled human foreskin fibroblasts revealed that a chromatin-associated glycopolypeptide with the approximate tool. wt. 130000 (130K) is induced in response to either infection with human cytomegalovirus (HCMV) or serum treatment. Comparative limited proteolysis suggested that the [3H]glucosamine-labelled 130K polypeptides induced by these different stimuli were not identical. This observation was in contrast to results obtained by immunoprecipitation with antisera raised against the 130K glycopolypeptide from serum-induced cells which favoured a relatedness to the 130K polypeptide from virusinfected cultures. Two-dimensional separation by isoelectric focusing and SDSpolyacrylamide gel electrophoresis subsequently showed that the 130K glycopolypeptide from serum-induced cells consists of two components, one of which is identical to the single component observed in samples from HCMV-infected cultures. Experiments on the effect of glycosylation inhibitors on DNA replication in HCMV-infected as well as in serum-induced cells support the view that the host-specific chromatin-associated glycopolypeptide may be involved in DNA replication in infected cells.
INTRODUCTION
There is ample information that inhibition of virus multiplication by sugar analogues or tunicamycin is primarily due to interference by these drugs with the proper synthesis and assembly of envelope glycoproteins necessary for virus infectivity (Courtney et al., 1973; Gallagher et al., 1973; Scholtissek, 1975) . On the other hand, glycosylation inhibitors may also exhibit inhibitory activity during the early phase of virus multiplication, as in the case of adenoassociated virus (AAV), where evidence has been presented that 2-deoxy-o-glucose (dGlc) eliminates the function of an 'early' viral glycopolypeptide of AAV and thus prevents initiation of viral DNA replication (Young & Mayor, 1979) . Inhibition of viral DNA synthesis in the presence of glycosylation inhibitors has recently been reported for a second system, human fibroblasts infected by cytomegalovirus (HCMV; . It is of interest in this context that two glycopolypeptides have been identified among the 'early' HCMV-induced proteins (Stinski, 1977) . Data on the subcellular distribution, source (i.e. virus-coded or hostspecific) and function of these glycosylated polypeptides were not described in this study. With respect to subcellular distribution, previous experiments with HCMV-infected cells in this laboratory had suggested that products whose induction is sensitive to glycosylation inhibitors may separate with chromatin upon cell fractionation (Radsak & Weder, 1981a) . Here we present evidence that one 'early' HCMV-induced glycopolypeptide found in association with chromatin preparations is host-specific and may function in DNA replication in infected cells. subsequently, human serum negative for 'early' HCMV-induced antigens were added to the mixture at a final concn, of 5~ and incubated for 90 min at 4 °C prior to addition of 100 ~tl/ml Immunoprecipitin (Bethesda Research Laboratories). Agitation of the suspension for 15 min at room temperature was followed by sedimentation in a Beckman model B microfuge, and incubation of the precleared extracts overnight at 4 °C with 20 to 50 ~tl/ml specific antiserum. Immune complexes were analysed by SDS-PAGE and fluorography after adsorption on Immunoprecipitin as described for the preclearing step and four subsequent washings with 50 mM-Tris-HCl pH 7.4, 0.5 M-LiCI, 0-1 M-NaCI and 1% (v/v) NP40.
Partial proteolysis. TCA-precipitated polypeptides obtained after electrophoretic elution from gel slices were partially digested with various amounts of V8 protease from Staphylococcus aureus (Miles Laboratories) during SDS-PAGE exactly as described by Cleveland et al. (1977) . After SDS-PAGE, gel slabs were processed for fluorography.
Determination of radioactivity, protein and DNA content. Acid-insoluble radioactivity was determined by collecting TCA precipitates on filters as described previously . DNA was extracted by phenol~hloroform (Hirai & Watanabe, 1976 ) before TCA precipitation. Protein content was estimated by the method of Lowry et al. (1951) , and DNA content by the procedure of Giles & Myers (1965) .
RESULTS

Identification of glycopolypeptides in chromatin preparations from HCMV-or serum-induced HFF
In order to show the presence of glycopolypeptides in chromatin preparations of HFF, confluent cultures (2 × 107 cells) of serum-starved (DeMarchi & Kaplan, 1977; a) cells were exposed to HCMV infection in the presence of PAA and 0.2% serum. In addition to mock-infected cultures, serum-starved cells stimulated by 15 % serum were used in a parallel experiment as controls. Untreated HCMV-infected cultures were not examined in this context as late viral functions which include numerous glycopolypeptides would have complicated this initial analysis and are unlikely to participate in early regulatory events of DNA replication in infected cells. For glycopolypeptide labelling 5 ~tCi/ml [3H]glucosamine was added to the culture medium from 36 to 48 h after onset of the experiment prior to harvest and cell fractionation (Yamada et al., 1978) . The proteins were solubilized from the chromatin fraction (see legend to Fig. 1 and Methods) and analysed by SDS-PAGE (Laemmli, 1970) and subsequent fluorography (Bonner & Laskey, 1974) . Fig. 1 shows that glycopolypeptides were present under our experimental conditions in all chromatin preparations examined. The main band of radioactivity in each track appeared in the range of mol. wt. 130K. In addition, bands containing minor amounts of radioactivity with higher as well as lower electrophoretic mobilities were also observed. In chromatin extracts from serum-induced cells ( Fig. 1 c) those of higher molecular weight were more prominent, whereas extracts of chromatin from PAAtreated HCMV-infected cultures ( Fig. l b) consistently exhibited relatively strong diffuse radioactivity in the 90000 to 95000 mol. wt. range which could not be detected in the other samples.
Induction of glycosylation of chromatin-associated polypeptides by 'early' functions of HCMV or by serum
Following a comparable experimental schedule to that described, pulse labelling with 5 I.tCi/ml [3H]glucosamine for 12 h intervals (see legend to Fig. 2 ) was used to study the temporal relationship of precursor incorporation to onset of HCMV infection or serum treatment. The fluorogram in Fig. 2 shows a representative result: mock-infected controls (Fig. 2 , tracks a' to c') exhibited an unchanged pattern of radioactive bands with decreasing intensity during the second and third pulses. HCMV infection and serum treatment (Fig. 2, tracks d' tof' and g' toj' respectively), on the other hand, resulted after initial depression during the first pulse in induction of glycosylation of the prominent 130K polypeptide during the second pulse interval (Fig. 2 , tracks e' and h'). Enhanced labelling of this polypeptide which evidently persisted after serum stimulation during the consecutive pulses was, however, found to decline beyond 48 h in HCMV-infected preparations (Fig. 2, tracksf', i' andj') . A further difference between the two stimuli is obvious with regard to the kinetics of labelling of the glycopolypeptides in the 150 000 to 200000 mol. wt. range. HCMV infection apparently rapidly inhibits glycosylation of these high molecular weight polypeptides whereas serum treatment results only in an eventual decrease. With respect to the low molecular weight polypeptides kinetic variations were inconsistent and are not considered here.
Effect of dGlc on synthesis of chromatin-associated polypeptides
The following experiments served to (i) clarify whether induction of [3H]glucosamine incorporation was paralleled by induction of polypeptide synthesis and (ii) trace the influence of dGlc on synthesis of the glycopolypeptides. The identical experimental sequence as above was thus repeated using [3H]leucine and [3H]lysine (2.5 ~tCi of each/ml) for pulse labelling at various times post-infection or after serum addition respectively ( Fig. 3) . One set each of HCMVinfected and serum-treated cultures were kept in the presence of dGlc. Identification of the 130K polypeptide during electrophoretic analysis was attempted by co-electrophoresis of [3H]glucosamine ( Fig. 3, tracks b ) and 3H-amino acid-labelled ( Fig. 3 , tracks a) samples.
It is evident from Fig. 3 (A, tracks a) that under our conditions synthesis in PAA-treated infected cells of a 130K polypeptide concomitant to its glycosylation is only observed during the first pulse. Subsequently these two events are dissociated, in particular during the second pulse when glycosylation is increased (Fig. 3A , track P2, b) and the 3H-amino acid label is almost completely absent in the identical position of Fig. 3 on the other hand, results in both induction of glycosylation as well as synthesis of the 130K polypeptide. The increase of 3H-amino acid label during the second and third pulse ( Fig. 3 B , tracks a of P2, P3) is, however, much less pronounced than that of [3H]glucosamine label ( Fig.  3B , tracks b of P2, P3). Evaluation of the fluorograms of preparations from cultures treated with dGlc (3 to 5 mM) which inhibits cellular glycosylation nearly completely as measured by [3H]glucosamine incorporation (not shown) yielded the following observations. The most obvious effect of dGlc on both HCMV-infected as well as serum-stimulated cells is the prominent induction of synthesis of a polypeptide with approx, mol. wt. 80000 (80K) which is labelled with about equal intensity during all three pulses ( Fig. 4A and B , tracks P1 to P3). Furthermore, it is apparent in Fig. 4 (B, tracks P1 to P3), representing serum-stimulated cells, that radioactivity in the 130K position is selectively reduced after dGlc treatment. In the case of chromatin from dGlc-treated HCMV-infected cells a comparable loss of label in this molecular weight range is not observed (Fig. 4A , tracks P1 to P3).
By comparing the pattern of chromatin-associated polypeptides from drug-treated infected cells labelled at late times post-infection (Fig. 4A, dGlc P3) with that from PAA-treated and untreated infected cells (Fig. 4A, E Weder, 1981 a). The sugar derivative does, however, allow expression of most of the 'early' virusinduced polypeptides that are distinguishable in chromatin preparations of PAA-treated cells (Fig. 4A , tracks dGlc P3 and E respectively).
Relatedness of the 130K glycopolypeptides from HCMV-inJected and serum-stimulated cultures
The induction of glycosylation of the 130K ehromatin-associated polypeptides by H C M V as well as serum prompted experiments to examine their relatedness, i.e. to determine whether the 130K glycopolypeptide from HCMV-infected cultures represents an 'early' virus-specific or virus-induced host-specific product. Three methods, comparative limited proteolysis (Cleveland et al., 1977) , immunoprecipitation (Blanton & Tevethia, 1981) with antisera of various specificities and two-dimensional separation by isoelectric focusing and SDS P A G E (2D-P A G E ; O'Farrell, 1975) were employed in an attempt to solve this question.
For limited proteolysis the 130K glycopolypeptides were isolated by electrophoretic elution from SDS-slab gels of chromatin extracts from [3H]glucosamine-labelled induced cells (pulse 2 in most of the experiments) and subjected to treatment with V8 protease.
The fluorogram in Fig. 5 demonstrates that partial digestion yielded patterns for the glycopolypeptide from serum-stimulated cells that were significantly different from those for the polypeptide from infected cultures, inferring that the latter may be virus-specific.
Contrasting results were obtained during immunoprecipitations using sera of various specificities. In addition to human sera, known to be positive for 'early' viral antigens, an antibody raised in rabbits against the 130K glycopolypeptide isolated from chromatin preparations of serum-stimulated cultures by preparative S D S -P A G E and electrophoretic elution from gel slices (see Methods) was used. This latter antiserum specifically immunoprecipitated the [3H]glucosamine-labelled 130K polypeptide from chromatin extracts of seruminduced as well as that from HCMV-infected cultures (Fig. 6) as revealed by subsequent SDS-P A G E of the precipitates and fluorography. The assays resulted consistently in precipitation also of polypeptides with molecular weights higher than 130K (Fig. 6) , an observation whose significance is unclear at present. In contrast, all attempts with antisera specific for 'early" viral antigens remained negative when chromatin extracts of [3H]glucosamine-labelled infected cells were examined. These antisera did, however, recognize virus-specific polypeptides in cytoplasmic extracts from 3Hamino acid-labelled infected cells (not shown). Analysis by 2D-PAGE subsequently solved the discordant results observed with comparative limited proteolysis and immunoprecipitat!on. As shown in Fig. 7 
Effect of dGlc on induction of DNA replication by H C M V or serum
We have recently shown that glycosylation inhibitors like dGlc and tunicamycin prevent HCMV-induced D N A replication in infected cells . Toxicity of the drug and effects via altered nucleotide pools (Scholtissek, 1975) could essentially be excluded (Radsak & Weder, 1981a) . Furthermore, chromatin preparations of HCMV-infected cells which have been shown previously to continue D N A replication under cell-free conditions exhibited significantly reduced endogenous replication activity when isolated from dGlc-treated infected cells (Radsak & Weder, 1981a) , an observation which favours the view of an association of 'dGlc-sensitive factors' with chromatin. Here we present evidence that a chromatin-associated glycopolypeptide is indeed induced by 'early' functions of H C M V concomitant to induction of D N A replication in infected cells (Radsak & Weder, 1981 a, b) . To substantiate the function of this glycosylated polypeptide in D N A replication, the action of dGlc on D N A synthesis, by serum-starved cells stimulated by serum, was examined. Table 1 shows drug-mediated prevention of induction of D N A replication in this non-viral model. Delayed addition of dGlc is effective until 12 h after onset of stimulation (Table 1, * Isolation of chromatin was performed at 48 h post-infection or serum stimulation respectively. Inhibitor treatment was initiated immediately post-infection or onset of serum stimulation. When dGlc was used as an inhibitor glucose was replaced by sodium pyruvate in the culture medium.
t Chromatin preparations were incubated with antisera for 30 min at 4 °C prior to use in the assay. ++ Conditions of incubation are described in Methods.
DISCUSSION
It has been shown recently that expression of HCMV antigens like that of herpes simplex virus is regulated by the sequential function of virus-specific 'immediate early' (IE), 'early' (E) and 'late' products (DeMarchi et al., 1980; Wathen et aL, 1981) . With regard to the antigens expressed at IE and E times post-infection a minimum of nine and ten polypeptides respectively, have been identified by in vitro translation of viral mRNA (Wathen et al., 1981) . Analysis of infected cells had previously yielded the additional observation that two of the 'early' virusinduced polypeptides with mol. wt. 145K and 100K are modified post-translation by glycosylation (Stinski, 1977) . Interestingly, no candidate correlate has been found, at least for the large polypeptide, in the in vitro translation studies reported (Wathen et al., 1981) . The chromatin-associated glycopolypeptide discussed in this study exhibits a molecular weight somewhat different from that of the large virus-induced glycopolypeptide described by Stinski (1977) . Considering, however, the difference in conditions used, e.g. cell cultures, virus strain and gel systems, as well as the fact that analysis of cell fractions other than chromatin has not yielded evidence for an additional virus-induced 'early' glycopolypeptide in that molecular weight range (D. Weder & K. D. Radsak, unpublished observation) we tend to believe that the 130K glycopolypeptide corresponds to the 145K product previously described (Stinski, 1977) . With regard to our rcsults from immunoprccipitations with antisera against the 130K polypeptide and against 'early' antigens of HCMV as well as to those obtained by comparative two-dimensional analysis it is suggested that the larger glycopolypeptide induced by HCMV under our conditions is a host-specific chromatin-associated product. The glycopolypeptide of 100K described by Stinski (1977) does not clearly separate with the chromatin fraction in our hands and will not be considered here.
Further work is needed to clarify why only the induction of glycosylation could be demonstrated but not the incorporation of amino acid into the 130K polypeptide of HCMVinfected cells. Furthermore, it is unclear at this point why serum stimulation results in induction of an additional glycosylated 130K component. It may be speculated that the more alkaline component represents a differently glycosylated form of the same polypeptide.
As to the function of the 130K glycopolypeptide, several arguments are thought to favour the view that this product is involved in DNA replication: the 130K glycopolypeptide is chromatinassociated and is induced in temporal relation to cellular DNA replication (Hirai & Watanabe, 1976; Radsak & Weder, 1981b) . Induced cultures treated with low concentrations of glycosylation inhibitors do not proceed to DNA replication and yield chromatin with significantly reduced in vitro replication activity (Radsak & Weder, 1981a) . It is pertinent to point out in this context that dGlc does not apparently interfere with expression of'early' virusinduced chromatin-associated polypeptides other than glycopolypeptides. The prominent induction of an 80K polypeptide in the presence of dGlc has to remain unexplained at this point. Further, more direct support for involvement of the 130K glycopolypeptide in cellular DNA replication comes from the use of the anti-130K sera in chromatin assays which produced only partial but consistent reduction in precursor uptake.
In conclusion, our results suggest that IE or E functions of HCMV are effective in inducing glycosylation of a host-specific 130K polypeptide which is essential for DNA replication. Preliminary experiments with our anti-130K serum do not support the assumption that the 130K polypeptide is a host cell DNA polymerase. Work is in progress to define the precise action of this cellular glycopolypeptide which possibly mediates stimulation of host cell DNA replication as a prerequisite for HCMV multiplication.
